nanomedicines with gold nanorods bounded with immune activator (Nanoaxis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenanomedicines with gold nanorods bounded with immune activator (Nanoaxis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsHemorrhagic Fever, EbolaHantavirus InfectionsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNanoAxis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNanoAxisCenters For Disease Control And Prevention
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, EbolaHantavirus InfectionsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A